|Title:||Price, availability and affordability: an international comparison of chronic disease medicines|
|Authors:||World Health Organization, Regional Office for the Eastern Mediterranean|
|Abstract:||Chronic diseases are a serious public health issue, particularly because they require long-term therapy. Ensuring access to medicines for treating chronic disease, however, remains neglected. In May 2001, the World Health Assembly adopted a resolution stating that WHO should explore systems for monitoring medicine prices with a view to improving access to essential drugs. WHO and Health Action International, in collaboration with a panel of experts, developed a methodology for surveying the prices, availability, affordability and components of medicine prices in developing and transitional countries. This report presents the synthesis data of 14 chronic disease medicines collected in 30 surveys that were undertaken using this methodology between 2001 and 2005. The key recommendation of this report is that to improve access to medicines for chronic diseases, governments should measure and continuously monitor the prices, availability and affordability of medicines and price components. They should also develop, implement and enforce policy options addressing these issues in order to reduce prices and make medicines affordable and available to their citizens|
|Description:||69 p. ; 30 cm.|
|Keywords:||Costs and Cost Analysis|
|Gov't Doc #:||WHO-EM/EDB/068/E|
|Appears in Collections:||EMRO Publications|
Items in WHO IRIS are protected by copyright, with all rights reserved, unless otherwise indicated.